Skip to main content

Table 1 The single polymorphisms of APOA5 gene and the association with obesity and metabolic syndromes

From: New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients

Gene

SNP/position

Association with diseases

APOA5

-1131 T > C

CAD

Elevated plasma TG

Elevated LDL-TG

Decreased HDL-C

Elevated VLDL-C

Decreased LDL particle size

Elevated TG after fasting

Elevated postprandial TG

Elevated postprandial VLDL

Higher dense postprandial LDL

Elevated postprandial CRP

Elevated total cholesterol

Elevated BMI

Elevated fat intake

Lower obesity risk

c.1259 T > C

Elevated plasma TG

Protective against obesity (alone)

c.56C > G

Higher BMI, waist and hip circumference

Extreme obesity (carried with LPL m107)

Decreased HDL

c.3A > G

Elevated metabolic syndrome risk

c.553G > T

Elevated metabolic syndrome risk

c.724C > G

Elevated plasma TG

IVS3 + 476G > A

Elevated plasma TG

  1. CAD coronary artery disease, TG triglyceride, LDL low density lipoprotein, VLDL very low density lipoprotein, LDL-C low density lipoprotein cholesterol, CRP C-reactive protein, LPL lipoprotein lipase, SNP single nucleotide polymorphism, BMI body mass index